CD8A and neoplasm: Yachi, P. P. team [55] found that tumor metabolites can inhibit the glycolysis of CD8+T cells, resulting in inhibition of cell proliferation, cytokine production, and cytotoxicity, resulting in damage to the anti-tumor effect of CD8+T cells.